NCT01441180View on ClinicalTrials.gov

GS-7977 With Ribavirin for Hepatitis C (SPARE)

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

March 31, 2013

Study Completion Date

July 31, 2014

Conditions
Hepatitis C
Interventions
DRUG

GS7977

drug intervention

DRUG

RBV

drug intervention

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT01441180 - GS-7977 With Ribavirin for Hepatitis C (SPARE) | Biotech Hunter | Biotech Hunter